Applied DNA Sciences第一季度每股收益$(0.56)不及预期$(0.28),销售额$1.20M超出预期$1.10M

财报速递02-14
Applied DNA Sciences (NASDAQ:APDN)报告季度每股亏损$(0.56),未达到分析师一致预期的$(0.28),相差100%。这比去年同期每股亏损$(0.09)减少了522.22%。公司报告季度销售额为$1.20百万,超出分析师一致预期的$1.10百万,超出8.67%。这比去年同期的销售额$891.16千增加了34.32%。

以上内容来自Benzinga Earnings专栏,原文如下:

Applied DNA Sciences (NASDAQ:APDN) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of $(0.28) by 100 percent. This is a 522.22 percent decrease over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $1.20 million which beat the analyst consensus estimate of $1.10 million by 8.67 percent. This is a 34.32 percent increase over sales of $891.16 thousand the same period last year.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法